Sort

Search

01/08/2022 Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Hemmig, AK, Gozzoli, D, Werlen, L, Ewald, H, Aschwanden, M, Blockmans, D, Brouwer, E, Buchanan, RRC, Camellino, D, Campochiaro, C, Cimmino, MA, Corominas, H, Gloy, V, Henckaerts, L, Kyburz, D, Moya-Alvarado, P, Owen, CE, Stegert, M, Tomelleri, A, van Sleen, Y, Yamashita, H, Imfeld, S, Berger, CT, Hemkens, LG, Daikeler, T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5.000(Q2/3D).
01/08/2022 A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
Zozaya N., Arrizubieta Basterrechea M.I., Bollo E., Castellví I., Espín J., Ortego N., Poveda-Andrés J.L., Rodríguez Portal J.A., Rivero A., Marcos-Rodríguez J.A., Verde L.. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1)DOI:10.1017/S0266462322000459. PMID:35912833. IF:3.200(Q2/5D).
01/08/2022 Transbronchial Cryobiopsy Bohemian Rhapsody
Torrego A., Pajares V., Maldonado F., Hetzel J.. Transbronchial Cryobiopsy Bohemian Rhapsody. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.004. PMID:35312593. IF:8.000(Q1/2D).
01/08/2022 How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?
Betancor, D, Olaguibel, JM, Rodrigo-Munoz, JM, Arismendi, E, Barranco, P, Barroso, B, Bobolea, I, Cardaba, B, Cruz, MJ, Curto, E, Del Pozo, V, Gonzalez-Barcala, FJ, Martinez-Rivera, C, Mullol, J, Munoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto, L, Valero, A, Valverde-Monge, M, Sastre, J. How reliably can algorithms identify eosinophilic asthma phenotypes using non-invasive biomarkers?. Clinical and Translational Allergy. 2022; 12(8)DOI:10.1002/clt2.12182. PMID:36000018. IF:4.400(Q2/5D).
01/08/2022 Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Tellez, MJ, Dominguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Roman, A, Santos, I, Giner, L, Arminanzas, C, Montero, M, Manzardo, C, Cifuentes, C, Garcia, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodriguez, C, Gaspar, G, Perez, L, Losa, JE, Force, L, Veloso, S, Martinez-Alfaro, E, Jarrin, I, De Miguel, M, Garcia, JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7)DOI:10.1111/hiv.13229. PMID:35037379. IF:3.000(Q3/7D).
01/08/2022 Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
Casado, JA, Valeri, A, Sanchez-Dominguez, R, Vela, P, Lopez, A, Navarro, S, Alberquilla, O, Hanenberg, H, Pujol, R, Segovia, JC, Minguillon, J, Surralles, J, de Heredia, CD, Sevilla, J, Rio, P, Bueren, JA. Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. JOURNAL OF CLINICAL INVESTIGATION. 2022; 132(15)DOI:10.1172/JCI142842. PMID:35671096. IF:15.900(Q1/1D).
01/08/2022 The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents
Atenza, CZ, Anguera, G, Melia, MR, De Lamo, LA, Sullivan, I, Joaquin, AB, Lopez, JS, Ortiz, MA, Mulet, M, Vidal, S, Majem, M. The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2022; 71(8)DOI:10.1007/s00262-021-03107-y. PMID:34984538. IF:5.800(Q1/3D).
01/08/2022 Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
Ramos-Muntada, M, Trincado, JL, Blanco, J, Bueno, C, Rodriguez-Cortez, VC, Bataller, A, Lopez-Millan, B, Schwab, C, Ortega, M, Velasco, P, Blanco, ML, Nomdedeu, J, Ramirez-Orellana, M, Minguela, A, Fuster, JL, Cuatrecasas, E, Camos, M, Ballerini, P, Escherich, G, Boer, J, DenBoer, M, Hernandez-Rivas, JM, Calasanz, MJ, Cazzaniga, G, Harrison, CJ, Menendez, P, Molina, O. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia. Molecular Oncology. 2022; 16(16)DOI:10.1002/1878-0261.13276. PMID:35726693. IF:6.600(Q1/3D).
01/08/2022 Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
Mena, M, Wang, X, Tous, S, Quiros, B, Clavero, O, Alejo, M, Morey, F, Taberna, M, Vintro, XL, Rubio, BL, Alos, L, Mehanna, H, Quint, W, Pawlita, M, Tommasino, M, Pavon, MA, Munoz, N, De Sanjose, S, Bosch, FX, Alemany, L. Concordance of p16(INK4a) and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study. Cancers. 2022; 14(15)DOI:10.3390/cancers14153787. PMID:35954451. IF:5.200(Q2/3D).
01/08/2022 Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan
Guijarro, F, Bataller, A, Diaz-Beya, M, Garrido, A, Coll-Ferra, C, Vives, S, Salamero, O, Valcarcel, D, Tormo, M, Arnan, M, Sampol, A, Castano-Diez, S, Martinez, C, Suarez-Lledo, M, Fernandez-Aviles, F, Hernandez-Boluda, JC, Ribera, JM, Rovira, M, Brunet, S, Sierra, J, Esteve, J. Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan. BONE MARROW TRANSPLANTATION. 2022; 57(8)DOI:10.1038/s41409-022-01703-9. PMID:35643942. IF:4.800(Q1/2D).
01/08/2022 TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
Ramos-Campoy, S, Puiggros, A, Kamaso, J, Bea, S, Bougeon, S, Larrayoz, MJ, Costa, D, Parker, H, Rigolin, GM, Blanco, ML, Collado, R, Ancin, I, Salgado, R, Moro-Garcia, MA, Baumann, T, Gimeno, E, Moreno, C, Salido, M, Calvo, X, Calasanz, MJ, Cuneo, A, Nguyen-Khac, F, Oscier, D, Haferlach, C, Strefford, JC, Schoumans, J, Espinet, B. TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype. Cancers. 2022; 14(15)DOI:10.3390/cancers14153715. PMID:35954380. IF:5.200(Q2/3D).
01/08/2022 Medical education, specialty training, and emergency medicine: when the whole is more than the sum of its parts
Campmany, MP, Montiel-Dacosta, JA, Higa-Sansone, JL, Romeu, JR. Medical education, specialty training, and emergency medicine: when the whole is more than the sum of its parts. EMERGENCIAS. 2022; 34(4)DOI:. PMID:35833772. IF:5.500(Q1/2D).
01/08/2022 Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response
Dato, VA, Benitez-Amaro, A, Garcia, E, Claudi, L, Lhoest, MTL, Iborra, A, Guerra, JM, Escola-Gil, JC, Samouillan, V, Enrich, C, Chiabrando, G, Llorente-Cortes, V. Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 152DOI:10.1016/j.biopha.2022.113270. PMID:35709652. IF:7.500(Q1/1D).
01/08/2022 CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4+T lymphocytes
Jimenez-Fernandez, M, Rodriguez-Sinovas, C, Canes, L, Ballester-Servera, C, Vara, A, Requena, S, de la Fuente, H, Martinez-Gonzalez, J, Sanchez-Madrid, F. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4+T lymphocytes. CELLULAR AND MOLECULAR LIFE SCIENCES. 2022; 79(8)DOI:10.1007/s00018-022-04481-1. PMID:35930205. IF:8.000(Q1/2D).
01/08/2022 Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2
Blasco-Perez, L, Costa-Roger, M, Leno-Colorado, J, Bernal, S, Alias, L, Codina-Sola, M, Martinez-Cruz, D, Castiglioni, C, Bertini, E, Travaglini, L, Millan, JM, Aller, E, Sotoca, J, Juntas, R, Hoei-Hansen, CE, Moreno-Escribano, A, Guillen-Navarro, E, Costa-Comellas, L, Munell, F, Boronat, S, Rojas-Garcia, R, Povedano, M, Cusco, I, Tizzano, EF. Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G > C Variant in SMN2. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158289. PMID:35955418. IF:5.600(Q1/3D).
01/08/2022 Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
Moreno, DF, Clapes, V, Soler, JA, Gonzalez-Montes, Y, Gironella, M, Motllo, C, Granell, M, Abella, E, Garcia-Pintos, M, Garcia-Guinon, A, Cabezudo, E, Blade, J, Rosinol, L. Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas. Clinical Lymphoma Myeloma & Leukemia. 2022; 22(8)DOI:10.1016/j.clml.2022.04.014. PMID:35610120. IF:2.700(Q3/7D).
01/08/2022 Audiovisual intervention alleviates anxiety of patients during PET/CT imaging
Abouzian, S, Camacho, V, Sabate, A, Stefaneli, P, Sizova, M, Gich, I, Lopez-Mora, D, Duch, J, Fernandez, A, Estorch, M, Carrio, I, Flotats, A. Audiovisual intervention alleviates anxiety of patients during PET/CT imaging. NUKLEARMEDIZIN-NUCLEAR MEDICINE. 2022; 61(04)DOI:10.1055/a-1759-4062. PMID:35931063. IF:1.500(Q4/9D).
01/08/2022 A Framework for the Development of Living Practice Guidelines in Health Care.
El Mikati IK, Khabsa J, Harb T, Khamis M, Agarwal A, Pardo-Hernandez H, Farran S, Khamis AM, El Zein O, El-Khoury R, Schünemann HJ, Akl EA, Alonso-Coello P, Alper BS, Amer YS, Arayssi T, Barker JM, Bouakl I, Boutron I, Brignardello-Petersen R, Carandang K, Chang S, Chen Y, Cuker A, El-Jardali F, Florez I, Ford N, Grove J, Guyatt GH, Hazlewood GS, Kredo T, Lamontagne F, Langendam MW, Lewin S, Macdonald H, McFarlane E, Meerpohl J, Munn Z, Murad MH, Mustafa RA, Neumann I, Nieuwlaat R, Nowak A, Pardo JP, Qaseem A, Rada G, Righini M, Rochwerg B, Rojas-Reyes MX, Siegal D, Siemieniuk R, Singh JA, Skoetz N, Sultan S, Synnot A, Tugwell P, Turner A, Turner T, Venkatachalam S, Welch V, Wiercioch W. A Framework for the Development of Living Practice Guidelines in Health Care.. ANNALS OF INTERNAL MEDICINE. 2022; 175(8)DOI:10.7326/M22-0514. PMID:35785533. IF:39.200(Q1/1D).
01/08/2022 Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021)
Laukhtina, E, Shim, SR, Mori, K, D'Andrea, D, Soria, F, Rajwa, P, Mostafaei, H, Comperat, E, Cimadamore, A, Moschini, M, Teoh, JYC, Enikeev, D, Xylinas, E, Lotan, Y, Palou, J, Gontero, P, Babjuk, M, Witjes, JA, Kamat, AM, Roupret, M, Shariat, SF, Pradere, B. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021). European Urology Oncology. 2022; 5(4)DOI:10.1016/j.euo.2022.01.003. PMID:35063436. IF:8.200(Q1/1D).
30/07/2022 Reforms to accelerated approval of new medicines: long overdue
Hwang, TJ, Trinh, QD, Tibau, A, Vokinger, KN. Reforms to accelerated approval of new medicines: long overdue. LANCET. 2022; 400(10349)DOI:10.1016/S0140-6736(22)01276-4. PMID:35835129. IF:168.900(Q1/1D).